Want to see VEEV full AI Analyst Report?
VEEV Stock Chart & Stats
$186.24
$6.66(3.71%)
At close: 4:00 PM EDT
$186.24
$6.66(3.71%)
Day’s Range― - ―
52-Week Range$148.05 - $310.50
Previous CloseN/A
Volume1.06M
Average Volume (3M)2.10M
Market Cap
$33.10B
Enterprise Value$18.68K
Total Cash (Recent Filing)$7.31B
Total Debt (Recent Filing)$103.07M
Price to Earnings (P/E)35.4
Beta0.87
Next Earnings
Sep 02, 2026EPS Estimate
2.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.76
Shares Outstanding162,443,300
10 Day Avg. Volume1,351,106
30 Day Avg. Volume2,100,069
Financial Highlights & Ratios
PEG Ratio1.42
Price to Book (P/B)4.63
Price to Sales (P/S)10.44
P/FCF Ratio24.08
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$238.45Price Target Upside28.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering22
EPS Forecast (FY)9.06
Revenue Forecast (FY)$3.65B
Bulls Say, Bears Say
Bulls Say
Recurring Subscription ModelVeeva’s subscription-heavy model in regulated life sciences creates durable recurring revenue, multi-year contracts and high switching costs. This fosters predictable cashflows and expansion upside via add-on modules, data subscriptions and cross-sell into Vault, supporting steady revenue visibility over months.
High Gross And Net MarginsSustained high gross and net margins reflect scalable SaaS economics and specialized life-sciences products. Strong margin profile provides internal cash to fund R&D, M&A and product scaling while absorbing incremental services cost pressure, preserving long-term profitability even if top-line slows.
Conservative Balance SheetAn exceptionally conservative balance sheet with minimal leverage gives Veeva optionality to invest in AI, R&D and tuck‑ins (eg, Ostro) and to weather macro shocks. Low solvency risk preserves strategic flexibility for multi-quarter product scaling or opportunistic M&A without funding strain.
Bears Say
Revenue Growth DecelerationRevenue growth slowing to mid-single digits from prior high-single to mid‑teens reduces the runway for operating leverage and raises pressure on management to generate expansion from Vault CRM, Crossix and data products. Persistent deceleration would constrain long‑term growth expectations and strategic investments.
Weakened Free Cash Flow ConversionA sharp drop in FCF conversion versus net income weakens cash quality: reduced free cash limits capacity for inorganic investments, buybacks or higher-risk R&D. If conversion remains depressed, Veeva’s ability to self-fund AI scaling and service expansions over the next few quarters is constrained.
AI Execution And Scaling RiskAgentic offerings like Falcon are early-stage and require significant product, data and compliance work before material monetization. Execution risk and regulatory proofs can delay benefits and elevate R&D and implementation costs, pressuring near-to-medium term returns on AI investments.
Veeva Systems News
VEEV FAQ
What was Veeva Systems’s price range in the past 12 months?
Veeva Systems lowest stock price was $148.05 and its highest was $310.50 in the past 12 months.
What is Veeva Systems’s market cap?
Veeva Systems’s market cap is $33.10B.
When is Veeva Systems’s upcoming earnings report date?
Veeva Systems’s upcoming earnings report date is Sep 02, 2026 which is in 27 days.
How were Veeva Systems’s earnings last quarter?
Veeva Systems released its earnings results on Jun 03, 2026. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.139 by $0.101.
Is Veeva Systems overvalued?
According to Wall Street analysts Veeva Systems’s price is currently Undervalued.
Does Veeva Systems pay dividends?
Veeva Systems does not currently pay dividends.
What is Veeva Systems’s EPS estimate?
Veeva Systems’s EPS estimate is 2.22.
How many shares outstanding does Veeva Systems have?
Veeva Systems has 162,443,300 shares outstanding.
What happened to Veeva Systems’s price movement after its last earnings report?
Veeva Systems reported an EPS of $2.24 in its last earnings report, beating expectations of $2.139. Following the earnings report the stock price went down -0.067%.
Which hedge fund is a major shareholder of Veeva Systems?
Currently, no hedge funds are holding shares in VEEV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Veeva Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$238.45 (28.03% Upside)
$238.45 (28.03% Upside)
Blogger Sentiment
Bullish
VEEV Sentiment 77%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.05%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.57%
Trailing 12-Months
Company Description
Veeva Systems
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
VEEV Company Deck
VEEV Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong execution and several clear growth drivers: solid Q1 financials ($883M revenue; $395M non-GAAP operating income), durable momentum in Crossix, a healthy R&D pipeline, Vault CRM traction (150+ live customers, >80% win rate) and strategic M&A (Ostro). Management is investing in AI (Vault AI, Falcon) and new agentic labor offerings, but these are early-stage and expected to have immaterial revenue impact this year outside of Ostro. Margin guidance is conservative and investments in services and AI introduce some near-term cost dynamics. Overall, positive operational momentum and disciplined investment balanced against execution and scaling risk for transformational AI initiatives.View all VEEV earnings summariesVEEV Revenue Breakdown
58.18% North America
27.79% Europe
11.35% APAC
2.68% Middle East, Africa, and Latin America
VEEV Stock 12 Month Forecast
Average Price Target
$238.45
▲(28.03% Upside)
Technical Analysis
Ownership Overview
1.02% Insiders
23.75% Mutual Funds
4.69% Other Institutional Investors
44.96% Public Companies and Individual Investors